Indication

E. coli bronchitis

E. Read more about E. coli bronchitis

7 drugs 7 manufacturers

Advertisement

Drugs that treat it

Common E. coli bronchitis therapies.

Showing 1–7 of 7 drugs

AZTREONAM

SEPSIS CAUSED BY ENTEROBACTER·+57
APP PHARMACEUTI

AZTREONAM

SEPSIS CAUSED BY ENTEROBACTER·+57
APP/PREMIERPRO

AZTREONAM

BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
APP/NOVAPLUS

AZTREONAM

SEPSIS CAUSED BY ENTEROBACTER·+57
APP/FRESENIUS K

AZTREONAM

BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
Hospira

AZTREONAM

BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
FRESENIUS KABI

AZTREONAM

BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
FRESENIUS KABI
Filter & compare in the drug finder →Opens the drug finder with E. coli bronchitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About E. coli bronchitis.

E.

coli bronchitis is a lower respiratory tract infection characterized by acute or chronic inflammation of the bronchial mucosa caused by susceptible strains of the Gram-negative bacterium *Escherichia coli*.

While *E.

coli* is an uncommon cause of bronchitis in healthy individuals, it predominantly affects hospitalized patients, older adults, or immunocompromised individuals with underlying structural lung diseases, impaired airway clearance, or healthcare-associated microaspiration.

Pathophysiologically, colonization and invasion of the bronchial tree trigger inflammatory hyperemia, edema, and hypersecretion of purulent sputum, clinically manifesting as a productive cough, wheezing, dyspnea, fever, and bronchial wall irritation.

Personalize your experience

Follow E. coli bronchitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it